Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
The plant is expected to start commercial operations from Q4FY24
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
This facility will design & develop instruments, perform product reliability performance testing and verification
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
